Amicus Therapeutics Income Statement
View: Annual
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 1.8 | 0.0 | 0.0 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 46.3 | 45.9 | 20.2 |
| Depreciation & Amortization | 1.2 | 0.9 | 0.7 |
| Operating Income | (45.8) | (46.9) | (20.8) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 5.0 | 0.8 | 0.3 |
| Nonoperating Expenses | 0.3 | 0.3 | 0.1 |
| Income Before Taxes | (41.2) | (46.3) | (20.6) |
| Income Taxes | -- | -- | (0.6) |
| Net Income After Taxes | (41.2) | (46.3) | (20.0) |
| Continuing Operations | (41.2) | (46.3) | (20.0) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (41.2) | (46.3) | (20.0) |
| Total Net Income | (41.2) | (46.3) | (20.0) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (3.14) | (89.58) | -- |
| Dividends per Share | -- | -- | -- |





